In February 2020, DNA Capital invested in Sanar, a Brazil-based digital healthcare education platform offering high-quality and affordable training for medical students and physicians.

With DNA Capital’s support, Sanar expanded into postgraduate education, launching hybrid programs in Psychiatry, Cardiology, Emergency Medicine and other fields that prepare licensed physicians for competitive residency placements and specialization exams. The company also acquired Cetrus, a leading provider of advanced medical training, further amplifying its social impact by combining education with direct patient care. In 2024 alone, Sanar provided free medical services to more than 65,000 patients. Following DNA Capital’s entry, monthly course enrollment has grown from 19,900 to over 69,000 physicians and medical students.

Download